Atlas Private Wealth Advisors »

Outlook Therapeutics shares owned by Atlas Private Wealth Advisors

Quarter-by-quarter ownership of Outlook Therapeutics shares owned by Atlas Private Wealth Advisors from 13F filings

Historical chart of Atlas Private Wealth Advisors investment in Outlook Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Outlook Therapeutics held by Atlas Private Wealth Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Outlook Therapeutics by Atlas Private Wealth Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $11k 28k 0.39

More positions owned by Atlas Private Wealth Advisors

Spdr Ser Tr Portfolio S&p400 (SPMD)
Spdr Ser Tr Portfolio S&p600 (SPSM)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Spdr Ser Tr Portfli High Yld (SPHY)
Ishares Tr 7-10 Yr Trsy Bd (IEF)
First Tr Nas100 Eq Weighted SHS (QQEW)
Spdr Dow Jones Indl Average Ut Ser 1 (DIA)
Invesco Exchange Traded Fd T Large Cap Value (PWV)
Apple (AAPL)
Ishares Tr Core Div Grwth (DGRO)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Select Sector Spdr Tr Financial (XLF)
Global X Fds Nasdaq 100 Cover (QYLD)
Invesco Qqq Tr Unit Ser 1 (QQQ)

View all positions for Atlas Private Wealth Advisors

Top funds holding Outlook Therapeutics

Vanguard Group
Rosalind Advisors
Scotia Capital
Millennium Management
Bank of America Corporation
Barclays
Rhumbline Advisers
UBS Group
Ancora Advisors
Jpmorgan Chase & Co
Alliancebernstein
American International
Captrust Financial Advisors
Virtu Financial
Goldman Sachs Group

View all funds holding Outlook Therapeutics